24 related articles for article (PubMed ID: 19445040)
1. Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview.
Smolders L; Plat J; Mensink RP
J Nutr Metab; 2017; 2017():5415921. PubMed ID: 28695008
[TBL] [Abstract][Full Text] [Related]
2. A protocol for differentiation of human intestinal Caco-2 cells in asymmetric serum-containing medium.
Ferruzza S; Rossi C; Scarino ML; Sambuy Y
Toxicol In Vitro; 2012 Dec; 26(8):1252-5. PubMed ID: 22265977
[TBL] [Abstract][Full Text] [Related]
3. Anti-
Abramov VM; Kosarev IV; Machulin AV; Deryusheva EI; Priputnevich TV; Panin AN; Chikileva IO; Abashina TN; Manoyan AM; Akhmetzyanova AA; Blumenkrants DA; Ivanova OE; Papazyan TT; Nikonov IN; Suzina NE; Melnikov VG; Khlebnikov VS; Sakulin VK; Samoilenko VA; Gordeev AB; Sukhikh GT; Uversky VN; Karlyshev AV
Antibiotics (Basel); 2023 Dec; 13(1):. PubMed ID: 38247590
[No Abstract] [Full Text] [Related]
4. C/EBP-β Is Differentially Affected by PPARα Agonists Fenofibric Acid and GW7647, But Does Not Change Apolipoprotein A-I Production During ER-Stress and Inflammation.
van der Krieken SE; Popeijus HE; Konings M; Dullens SP; Mensink RP; Plat J
J Cell Biochem; 2017 Apr; 118(4):754-763. PubMed ID: 27618583
[TBL] [Abstract][Full Text] [Related]
5. PPARγ Represses Apolipoprotein A-I Gene but Impedes TNFα-Mediated ApoA-I Downregulation in HepG2 Cells.
Shavva VS; Mogilenko DA; Bogomolova AM; Nikitin AA; Dizhe EB; Efremov AM; Oleinikova GN; Perevozchikov AP; Orlov SV
J Cell Biochem; 2016 Sep; 117(9):2010-22. PubMed ID: 26813964
[TBL] [Abstract][Full Text] [Related]
6. Dietary oxidized fatty acids may enhance intestinal apolipoprotein A-I production.
Rong R; Ramachandran S; Penumetcha M; Khan N; Parthasarathy S
J Lipid Res; 2002 Apr; 43(4):557-64. PubMed ID: 11907138
[TBL] [Abstract][Full Text] [Related]
7. Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production.
Colin S; Briand O; Touche V; Wouters K; Baron M; Pattou F; Hanf R; Tailleux A; Chinetti G; Staels B; Lestavel S
Eur Heart J; 2013 Aug; 34(32):2566-74. PubMed ID: 22843443
[TBL] [Abstract][Full Text] [Related]
8. Butyric Acid Added Apically to Intestinal Caco-2 Cells Elevates Hepatic ApoA-I Transcription and Rescues Lower ApoA-I Expression in Inflamed HepG2 Cells Co-Cultured in the Basolateral Compartment.
Tayyeb JZ; Popeijus HE; Mensink RP; Plat J
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33430253
[TBL] [Abstract][Full Text] [Related]
9. Differentiated CaCo-2 cells as an in-vitro model to evaluate de-novo apolipoprotein A-I production in the small intestine.
Dullens SP; Mensink RP; Mariman EC; Plat J
Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):642-9. PubMed ID: 19445040
[TBL] [Abstract][Full Text] [Related]
10. Increasing apoA-I production as a target for CHD risk reduction.
Dullens SP; Plat J; Mensink RP
Nutr Metab Cardiovasc Dis; 2007 Oct; 17(8):616-28. PubMed ID: 17703927
[TBL] [Abstract][Full Text] [Related]
11. [New trends in lipidology: the increasing role of HDL-cholesterol].
Paragh G; Harangi M; László M
Orv Hetil; 2008 Jul; 149(30):1395-404. PubMed ID: 18621598
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
